No Comments
Strategic Contribution to Egypt’s COVID-19 Response
Strategic Contribution to Egypt’s COVID-19 Respons Mission Pharma successfully supported Egyptian health authorities during the COVID-19 pandemic by ensuring the supply of the country’s first Enoxaparin biosimilars, playing a pivotal role in maintaining access to essential anticoagulant therapies during a time of global uncertainty.
Mission Pharma Head Office
Building No. 6, Misr Aviation Association Division, next to Al Watany Eye Hospital, El Thawra Street, Heliopolis, Misr Al-Gedida – Cairo – Egypt
Mission Pharma Secondary Office
Mountain View ICity business park - new capital.
International Pioneers office (Mission Pharma affiliate)
3225, Ibn hubbira Street, Al Zahra District, Riyadh city, Saudi Arabia.
Mission Pharma Office 2 (Mission Pharma affiliate)
3171, Jabal Abi Naqba ST, AL Masani District, Riyadh City, Saudi Arabia.
Open Modal
-
HomeHome
-
Who We AreWho We Are
-
Discover the power of oneDiscover the power of one
-
ServicesServices
-
PartnersPartners
-
PortfolioPortfolio
-
CareerCareer
-
Contact UsContact Us
